Skip navigation
Skip navigation
You are using an outdated browser. Please upgrade your browser.

Firms across the pharmaceuticals sector continue to rely on contract resources as the economic uncertainty of the first half of 2024 dampened confidence. That’s according to the latest insights from the Association of Professional Staffing Companies (APSCo).



The data, provided by Veritone Hire, revealed that the number of professionals applying for contract roles in the pharmaceuticals sector increased 21% year-on-year in June 2024. In comparison, applications for permanent roles fell 37% during this time.



While the data did show a 15% fall in contract vacancies year-on-year in June, this far lower than the 46% decline noted in permanent jobs during the same period. According to APSCo, this suggests a continued reliance on contract skills during a period of economic uncertain in H1.



Ann Swain, Global CEO at APSCo, commented:



“There may have been a dip in vacancies, but the resilience of both contract work and applications that we’re seeing does suggest that hiring in pharmaceuticals remains strong. The data is showing a clear trend in reliance on the temporary labour market, which is an indication that the uncertainty the UK has seen so far this year has dampened permanent recruitment, but not necessarily skills needs. With a new Government now in place, we hope to see stability and growth in the sector once again.”







Press contact

Vickie Collinge

vickie@bluesky-pr.com

01582 790 705



About APSCo

The Association of Professional Staffing Companies (APSCo) is the trade association for the professional recruitment market. APSCo Global comprises APSCo Asia, APSCo Australia, APSCo Deutschland and APSCo United Kingdom as well as APSCo OutSource, the trade body for the RPO and MSP sectors.

Find out more: www.apscouk.orgwww.apscouk.org

This press release was distributed by ResponseSource Press Release Wire on behalf of BlueSky Public Relations Ltd in the following categories: Medical & Pharmaceutical, for more information visit https://pressreleasewire.responsesource.com/about.